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Motor disturbances: symptoms 
or side effects?
otor deficits are common and disabling symp-
toms in schizophrenic patients, and have an enormous
impact on the long-term outcome of the disease by
affecting work performance and daily functioning. A
major problem for the clinician is that motor distur-
bances in schizophrenic patients can be caused by
dopamine-blocking antipsychotic medication,but they
can also be a primary symptom of the disorder itself.This
is quite obvious in catatonic schizophrenia,but,even in
noncatatonic schizophrenic patients,subtle disturbances
of psychomotor performance–the so-called neurological
soft signs–can frequently be observed.
When treated with antipsychotic agents,a certain num-
ber of patients exhibit extrapyramidal side effects,such
as dystonia, akathisia, dyskinesia, and neuroleptic-
induced parkinsonism (NIP). Epidemiological studies
have displayed extremely varying NIP prevalence rates
in schizophrenic patients,ranging from 5% to 90%.
1-3 On
the other hand,studies in first-episode neuroleptic-naive
patients have revealed that psychomotor disturbances
are also present at the onset of illness,as well as in clini-
cally unaffected relatives of schizophrenic patients.
4
Psychomotor disturbances in unmedicated schizophren-
123
Clinical research
M
Copyright © 2006 LLS SAS.  All rights reserved www.dialogues-cns.org
Quantitative analysis of motor disturbances
in schizophrenic patients 
Albert Putzhammer, MD; Helmfried E. Klein, MD 
Keywords: schizophrenia; motor disturbance; antipsychotic treatment; psycho-
motor disturbance; quantitative movement analysis
Author affiliations: Department of Psychiatry, University of Regensburg,
Regensburg, Germany 
Address for correspondence: Albert Putzhammer, MD, Department of Psychiatry
and Psychotherapy, University of Regensburg, D-93042 Regensburg, Germany
(e-mail: albert.putzhammer@medbo.de)
The presence of neurological signs and disturbed psy-
chomotor performance have been consistently confirmed
by clinical studies in schizophrenic patients. These para-
meters are mainly assessed by using clinical rating scales.
In recent years, new approaches such as ultrasonic move-
ment analysis systems have been introduced in order to
objectively evaluate motor disturbances in schizophrenic
patients. Ultrasonic movement analysis systems calculate
the three-dimensional positions of tiny markers, which are
attached to moving body parts, with high spatial and tem-
poral resolution. Thus, key parameters of gait and hand
movements can be determined precisely. This article sum-
marizes and discusses several studies using these new
methods. Results indicate that schizophrenia causes a spe-
cific motor deficit pattern, with a predominant distur-
bance of spatial parameters. Conventional antipsychotic
treatment usually worsens these deficits, whereas the
effects of atypical antipsychotic treatments are less pro-
nounced. Disturbed motor performance can be normal-
ized by external sensory stimuli, but only when no major
attentional processes are required, and it can be enhanced
by an attentional strategy, but not to the extent that
motor parameters are normalized.     
© 2006, LLS SAS Dialogues Clin Neurosci. 2006;8:123-130.ics have been interpreted as manifestations of dysfunc-
tional neural connections between subcortical and corti-
cal areas,or of defective brain structures.
5-7 Gupta et al
made the point that neurological abnormalities in schiz-
ophrenic patients may be present independently of side
effects of medication, but that antipsychotics do con-
tribute to their prevalence.
5
Motor disturbances and subjective well-being
In schizophrenia,the subjective well-being of the patients
may not only be affected by the disabling symptoms of
the disorder,but also by side effects of the antipsychotic
treatment.Antipsychotic treatment has been associated
with a variety of motor side effects,as well as affective,
cognitive,and social impairments,which can reduce qual-
ity of life.
8-12 Motor disturbances are associated with a
substantial reduction in the patient’s quality of life and
in compliance with the treatment.Van Putten found a sig-
nificant relationship of noncompliance with motor side
effects,particularly with akathisia.
13
In this context,we assessed the correlations of subjective
well-being with objectively measured gait parameters,
expert-rated motor disturbances,and psychopathological
status in conventionally treated, atypically treated, and
drug-naïve patients.
14The main variables were the SWN
(Subjective Well-being under Neuroleptic Treatment
Scale) scores,
15 the ESRS (Extrapyramidal Rating Scale)
scores,
16 and the PANSS (Positive and Negative Syndrome
Scale) scores.
17The SWN is a 20-item self-rating scale,con-
sisting of five subscales:emotional regulation,self-control,
mental functioning,social integration,and physical func-
tioning.It does not require patients’ distinction between
pharmacogenic and morbogenic components.Spatial and
temporal parameters of gait were measured by using an
ultrasonic system for gait analysis.
The study revealed three major results:first,in conven-
tionally treated patients,the SWN total score significantly
correlated with stride length (R
2=0.39;P<0.01),whereas
in atypically treated and drug-naïve patients it signifi-
cantly correlated with the PANSS score (atypically
treated:R
2=0.25,P<0.05;drug-naïve:R
2=0.64,P<0.01),
mainly due to the correlations with the “negative symp-
toms” and the “general psychopathology” subscores.
Second,correlations with stride length were significant,
not only in the “physical functioning” subscore of the
SWN,but also in all other subscores.And third,correla-
tions of the SWN scores with ESRS scores were weak.
Consequently,these results suggest that,under conven-
tional antipsychotic treatment,subjective well-being par-
ticularly depends on motor side effects,whereas in atyp-
ically treated and drug-naïve schizophrenic patients it is
mainly influenced by the psychopathological status.
Additionally,motor adverse effects of antipsychotic treat-
ment can not be considered as isolated physical side
effects,but have severe implications for other aspects of
the patients’ well-being. The results also suggest that
objectively measured parameters of motor performance
represent the influences of motor disturbances on sub-
jective well-being much more closely than the expert rat-
ing,the ESRS.Thus,the use of quantitative methods in
the assessment of motor disturbances of schizophrenic
patients might be very useful and promising.
How can motor disturbances be measured?
Most studies on psychomotor performance in schizo-
phrenic patients have restricted their work to the assess-
ment of motor disturbances by using clinical ratings,such
as the ESRS,
16 the Abnormal Involuntary Movement
Scale (AIMS),
18 the Barnes Akathisia Scale (BAS),
19 and
others.Almost all clinical trials on antipsychotic treat-
ment have used one or more of these clinical ratings for
the detection of motor side effects.
More specific studies on psychomotor disturbances in
schizophrenic patients additionally used clinical observa-
tions and ratings of the performance of special motor tasks.
For example,a common test for subtle psychomotor dis-
turbances and disturbed motor coordination in schizo-
phrenic patients is the performance of diadochokinetic
movements.This is tested by asking the patient to alternate
between pronation and supination of the hand.Motor dis-
turbances in schizophrenic patients can also be detected by
analyzing the patient’s handwriting,as shown by Haase as
early as the 1950s in his tests of the effects of neuroleptic
treatment on writing.
20 Some authors have observed clini-
cal pictures of gait disturbances in schizophrenic patients.
However, despite the high frequency of dysfunctional
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Selected abbreviations and acronyms
ESRS Extrapyramidal Symptom Rating Scale
PD Parkinson's disease
PMC premotor cortex
SMA supplementary motor area
SWN Subjective Well-being under Neuroleptic treatment 
scalemotor performance in schizophrenic patients,very few
studies have attempted to quantify these disturbances by
using an objective method.
21,22 The lack of studies on
quantitatively measured spatial and temporal parameters
of motor performance in schizophrenic patients is mir-
rored by the lack of knowledge on the pathogenesis of
motor disturbances in psychiatric diseases in general.In
this context, we introduced a three-dimensional ultra-
sonic movement analysis system into our investigations
on psychiatric disorders.
Three-dimensional ultrasonic 
movement analysis
In our studies, spatial and temporal parameters were
assessed with the Zebris CMS70P; MA70P3 system
(Zebris Medical Systems, Tübingen, Germany). This
three-dimensional movement analysis system can be flex-
ibly used in the assessment of spatial and temporal para-
meters of various movements.We used it mainly for the
analysis of gait and hand movements.The system is based
on an ultrasonic movement analysis system that continu-
ously calculates the three-dimensional spatial positions of
tiny markers (diameter 0.8 mm) which are attached to
precisely defined positions on moving body parts.The
ultrasonic system evaluates transmission times of ultra-
sound impulses (40 kHz),emitted from these markers and
received by three microphones mounted on a stationary
frame.Thus,a local coordinate system is determined,and
three-dimensional coordinates of the markers can be
derived by triangulation (Figure 1).By this technique,the
spatial positions of the markers are sampled at a fre-
quency of up to 100 Hz, which corresponds a temporal
resolution of 10 ms.The spatial resolution of the system is
less than 0.6 mm.Many spatial and temporal motor para-
meters can be computed by using special software pack-
ages.Excellent reproducibility and accuracy of the device
has been demonstrated in several studies.
23;24
Analysis of gait disturbances in patients
By using this system,we assessed the locomotor patterns
of gait in schizophrenic patients and differentiated intrin-
sic effects of the illness from those caused by conven-
tional and atypical neuroleptic treatment.
25 Gait para-
meters of 16 drug-naïve, 25 conventionally treated
(haloperidol:n=17,mean dose 6.4 +/- standard deviation
[SD] 3.4 mg/day; fluphenazine: n=5, 11.2 +/- SD 7.7
mg/day;flupentixol:n=3,6.7 +/- SD 2.9 mg/day) and 25
atypically treated patients (olanzapine:n=20,mean dose
16.2 +/- SD 6.3 mg/day;amisulpride:n=5;560 +/- SD 89
mg/day),as well as 25 control subjects,were evaluated.
Differences in gait velocity and in stride length between
the four investigated groups were highly significant
(analysis of variance [ANOVA]: P<0.001). Mean gait
velocities of all patient groups were significantly slower
than those of controls,with the most striking difference
observed between the control group and patients treated
with conventional neuroleptics (P<0.001).Amongst the
patient groups, significant differences were detected
between patients treated with conventional neuroleptics,
and both patients treated with atypical neuroleptics and
drug-naïve patients (P<0.05),but not between untreated
and atypically treated patients.
In all patient groups the reduction in gait velocity was
due to a smaller mean stride length,while the cadence
(steps per minute) was not changed.
These results indicate that schizophrenia causes a primary
disturbance of stride length regulation. Conventional
antipsychotic treatment intensifies this deficit, whereas
atypical antipsychotic treatment does not cause any addi-
tional gait disturbances.In contrast to the spatial parame-
ters, the temporal structure of schizophrenic gait is not
affected either by antipsychotic treatment or schizophre-
nia itself.
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Figure 1. Ultrasonic movement analysis: calculation of the three-dimen-
sional spatial position (coordinates: x, y, z) of ultrasonic emit-
ters on the different transmission times (t1-3) of the ultrasound
signals to the three microphones. US, ultrasonic.
US microphones
US emitter
z
y
t1
t2
t3
xEffect of external sensory stimulation by
treadmill walking
In this study, gait parameters of 14 drug-naive schizo-
phrenic patients,14 patients treated with conventional
antipsychotics (haloperidol:n=10,mean dose 6.7 +/- SD
3.5 mg/day;fluphenazine:n=4,13.0 +/- SD 6.78 mg/day)
14 patients treated with olanzapine (17.7 +/- SD 5.7
mg/day),as well as 14 matched controls,were assessed on
a walkway and on a treadmill at three different velocities
(very slow,intermediately slow,and comfortable).
26
In Parkinson’s disease (PD) studies indicate that condi-
tions involving the use of exteroceptive information may
facilitate movement.Although PD patients typically walk
with smaller steps,they achieved the desired stride ampli-
tude when provided with external cues while walking on
a treadmill.
27 External stimulation is supposed to lead to
an activation of a correct stepping response by triggering
the use of nonaffected brain areas.
Parallel to the results of the abovementioned study on
free gait,in this study all patients showed a significantly
decreased gait velocity,predominantly due to a shorter
stride length,when compared with the controls.The most
striking difference could be observed between the
patients treated with conventional neuroleptics and the
controls (ANOVA: P≤ 0.001). Cadence (steps per sec-
ond) did not differ between the investigated groups.
When gait was evaluated on the treadmill,differences in
stride length and cadence were significant only at the
very slow treadmill velocity (ANOVA: P≤ 0.05). In all
patient groups, mean stride length was decreased and
cadence compensationally increased.Significant differ-
ences between the patient groups were no longer
detectable.With increasing treadmill velocities,gait para-
meters of all patient groups were totally normalized.
The results show that,as in patients with PD,impaired
gait parameters can also be normalized in schizophrenic
patients by external stimulation via treadmill walking,but
only at normal gait velocities,not at slow gait velocities.
Analysis of diadochokinetic hand movements
This study assessed the impact of schizophrenia and of
antipsychotic treatment on diadochokinesia in 20 drug-
naïve patients, 20 patients conventionally treated with
antipsychotics (haloperidol:n=13,mean dose 7.6 +/- SD
3.6 mg/day; fluphenazine: n=7, 6.7 +/- SD 3.2 mg/day),
and 20 atypically treated (olanzapine: 16.8 +/- SD 6.4
mg/day) patients,as well as in 20 healthy controls.
28
The study revealed that amplitude and peak velocity of
diadochokinetic hand movements were significantly
reduced in all patient groups compared with the controls,
while frequency of the repetitive movement remained
unaffected.The reduction was most pronounced in the
conventionally treated patients.In addition,peak accel-
eration and movement automation were impaired,but
only on conventional antipsychotic treatment.
Effects of an attentional strategy
The study also tested the influences of disorder and med-
ication on motor enhancement as induced by an atten-
tional strategy.First,the patients were asked to perform
the movement “as quickly as possible.”In this instruction
there was no reference to the amplitude.Patients were
then asked to perform the movement “as quickly as pos-
sible,but now with the widest possible amplitude.”Thus,
the patient’s attention was drawn to the production of a
maximal amplitude.The background for this experiment
is that in patients with Parkinson’s disease the use of such
an attentional strategy leads to a normalization of the
disturbed movement parameters.
The analysis of the enhancing effect of an attentional
strategy on diadochokinesia showed that patients in all
groups were able to increase the amplitude,if they were
instructed to do so.Yet,the degree to which the ampli-
tude was increased was much smaller in the two patient
groups under antipsychotic treatment compared with
both the drug-naïve patients and the controls.This result
reveals a different enhancing effect under neuroleptic
treatment,but does not confirm the hypothesis that an
attentional strategy can normalize disturbed motor per-
formance in schizophrenic patients,as has been derived
from the observations in PD patients.
Discussion of the results and underlying
pathophysiological mechanisms
Summarizing the results of these studies on motor dis-
turbances in schizophrenic patients,we can state that:
• Motor disturbances severely impair the patient’s well-
being, and the degree of impairment is represented
much more closely by objectively measured parameters
than by expert ratings of motor performance.
• Drug-naive patients suffer from a primary motor deficit
with predominantly disturbed spatial parameters:gait
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whereas cadence (frequency) is normal,diadochokinetic
amplitude is decreased,and peak velocity and regularity
are hampered,whilst frequency again is not influenced.
• Conventional antipsychotic treatment regularly wors-
ens these specific primary deficits,whereas the effects
of atypical antipsychotic treatment are less pro-
nounced.
• Disturbed motor performance can be normalized by
external sensory stimuli, but–in contrast to PD
patients–only when no major attentional processes are
required.
• Disturbed motor performance can be enhanced by an
attentional strategy, but–again in contrast to PD
patients–not to the extent that motor parameters are
normalized. The enhancement of movement ampli-
tudes is much less pronounced in patients receiving
antipsychotic medication.
The pathophysiological mechanism underlying the
decrease in movement amplitude has not yet been eluci-
dated,either in PD or in schizophrenia.A fundamental
hypothesis explaining hypokinesia in PD states that,due
to overactivity of inhibitory projections from the basal
ganglia to the thalamus,thalamocortical projections fail
to facilitate the motor-related cortical areas such as the
supplementary motor area (SMA),cingulate motor areas
(CMA), and premotor cortex (PMC) (Figure 2).
29
Hypofunctioning of the SMA in PD patients during
movements has been demonstrated by studies using
functional magnetic resonance imaging (fMRI).
30 The
basal ganglia-SMA motor system, which regulates the
elaboration of internally driven motor sequences,may be
responsible for the adequate scaling of motor activity in
normal movement. PD patients fail in this process
because of the basal ganglia-SMA dysfunction.
31
fMRI studies on motor activation in schizophrenic
patients have also revealed decreased activation of the
SMA.
7,32,33Thus,reduction in SMA activity during motor
tasks seems to be a common characteristic in PD and
schizophrenia.Reduced SMA activity could be caused
by disturbed functioning,either of the cortico-cortical cir-
cuit via the basal ganglia and the thalamus,or of the cor-
tico-cerebellar-thalamic-cortical circuit (CCTCC).Both
defects would lead to a deficient thalamic output toward
the SMA.
Evidence from various research methodologies supports
the suggestion that a disordered function of neural cir-
cuits containing the basal ganglia and the thalamus has a
role in the pathophysiology of schizophrenia.
34,35 Studies
have revealed a disturbed basal ganglia output in schiz-
ophrenic patients who were treated with antipsychotic
medication.
36-38Additionally,dysfunction of the CCTCC
leading to poorly coordinated mental activity and altered
excitability of the motor cortex have been demonstrated
in untreated schizophrenic patients.
39,40
Problems with the regularity and smoothness of the move-
ment might also be caused by basal ganglia dysfunction,
but they are more likely to be caused by deficiencies in
monitoring and optimization of movement by the use of
sensory feedback information.As the cerebellum is mainly
involved in these processes, cerebellar dysfunctions in
schizophrenic patients could also contribute to the
observed disturbances in regularity and smoothness.
In PD,hypokinesia may improve under exposure to sen-
sory or emotional stimuli. Many studies have demon-
strated that PD patients can use diverse external cues or
attentional strategies to enhance motor performance.
27,41
Our results indicate that the normalizing effect of exter-
nal sensory stimuli on motor parameters in schizophrenic
patients is similar to that in PD patients, whereas the
effect of attentional stimuli is much less pronounced.The
pathophysiological basis for this finding remains unclear.
According to cerebral blood flow studies,activity in the
PMC and SMA is elevated in patients with PD when
external cues or attentional strategies are used to
enhance motor performance.
42 It is hypothesized that in
PD patients external cues and attentional strategies
enable the PMC and SMA to better compensate for
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Figure 2. Scheme of motor circuits involved in the pathophysiology of
movement disturbances in schizophrenic patients. PMC, pre-
motor cortex; SMA, supplementary motor area; CMA, cin-
gular motor area.
Somatosensory cortex
PMC
SMA
CMA
Frontal/
prefrontal
cortex
Thalamus
Basal
ganglia
Spinal cord
Cerebellum
Primary
motor
cortexdefective motor control mechanisms in the basal ganglia.
The lateral PMC is preferentially active during externally
cued movements,as opposed to non-cued movements,
43
and PMC and parietal overactivity has been reported in
PD patients during the performance of sensory-cued
motor tasks.
44
Hanakawa et al showed enhanced activation in the right
lateral PMC in PD patients while walking on a treadmill.
They concluded that a brain circuit including posterior
parietal cortex,cerebellum,and lateral PMC plays a key
role in the development of the paradoxically enhanced
gait induced by external stimuli in PD patients. The
authors suggested that utilization of nonaffected brain
areas is a compensatory mechanism for basal ganglia dys-
function in movement activation.
45
In our study, we also observed a compensation for the
impairment of stride-length regulation under external
stimulation via treadmill walking in all patient groups.As
in PD,external stimuli could enable the PMC and SMA
to better compensate for deficiencies in thalamo-cortical
output, caused either by antidopaminergic effects of
antipsychotic treatment or by a primary pathophysio-
logical condition of schizophrenia. In contrast to the
effects of external sensory stimuli on gait,we could not
demonstrate a normalization of diadochokinetic move-
ments under the use of an attentional strategy.This con-
trasts with the findings in PD patients.
The reason for the different enhancing effects of sensory
stimuli and attentional strategies in schizophrenic
patients is unclear.One possible explanation for the vari-
ation of the enhancing effects of treadmill walking at the
various velocities could be found in the varying degrees
of gait automation at the three tested gait velocities.Slow
and very slow gaits are poorly automated–especially
when performed on the treadmill–and require marked
cognitive processes, whereas gait at normal velocity is
highly automated. Thus, cognitive deficits in schizo-
phrenic patients could lead to additional deficits in the
generation of optimal gait patterns. These cognitive
deficits could also be the reason for the failure of atten-
tional strategies to normalize disturbed motor parame-
ters in schizophrenic patients, as has been observed in
our study on diadochokinetic movements.This suggests
that the pathophysiological processes underlying motor
disturbances in schizophrenic patients are much more
widespread than in PD patients,and also involve–in addi-
tion to the basal ganglia–cerebellar, frontal, and pre-
frontal structures.
In conclusion,the studies show that quantitative analyses
of motor disturbances can provide objective data on pri-
mary motor disturbances in schizophrenic patients,as well
as on motor side effects of various antipsychotic treatment
options.Thus,they can provide further insight in the patho-
physiological conditions of schizophrenia and of adverse
effects of antipsychotic treatment. Investigations of the
effects of enhancing strategies and the combination of
quantitative movement analysis with other methods,such
as genetic or functional imaging studies,could further con-
tribute to the identification of mechanisms underlying
motor disturbances in schizophrenia. ❏
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Análisis cuantitativo de las alteraciones
motoras en pacientes esquizofrénicos
Los estudios clínicos en pacientes esquizofrénicos
han confirmado sólidamente la presencia de signos
neurológicos y alteraciones en el rendimiento psi-
comotor. Estos parámetros se estudian utilizando
principalmente escalas de evaluación clínica.
Recientemente se han introducido nuevas aproxi-
maciones como los sistemas de análisis ultrasónico
del movimiento con la intención de evaluar obje-
tivamente las alteraciones motoras en los pacientes
esquizofrénicos. Los sistemas de análisis ultrasónico
del movimiento calculan las posiciones en tre
dimensiones de diminutos sensores, los cuales están
adosados a partes del cuerpo que se mueven, con
una alta resolución espacial y temporal. De este
modo se pueden determinar con precisión pará-
metros clave de la marcha y movimientos de la
mano. Este artículo resume y discute algunos estu-
dios que utilizan esta nueva metodología. Los resul-
tados indican que la esquizofrenia genera un
patrón específico de déficit motor, con una altera-
ción predominante de los parámetros espaciales.
Habitualmente el tratamiento antipsicótico con-
vencional empeora estos déficits, mientras que los
efectos de los tratamientos con antipsicóticos atí-
picos son menos pronunciados. La alteración del
rendimiento motor puede ser normalizada por estí-
mulos sensoriales externos, sólo cuando no se
requieren importantes procesos de atención, y
puede ser reforzada por una estrategia de aten-
ción, pero no en la cuantía en que son normaliza-
dos los parámetros motores. 
Analyse quantitative des troubles moteurs
chez les patients schizophrènes
Des  études cliniques chez des patients schizo-
phrènes ont régulièrement confirmé la présence de
signes neurologiques et un fonctionnement psy-
chomoteur perturbé. Ces paramètres sont princi-
palement évalués par des échelles d’évaluation cli-
niques. Ces dernières années, de nouvelles
approches comme les systèmes d’analyse de mou-
vement par ultrasons ont été introduites afin d’éva-
luer objectivement les troubles moteurs chez les
patients schizophrènes.  Les systèmes d’analyse de
mouvement par ultrasons calculent les positions en
trois dimensions de minuscules marqueurs attachés
aux parties mobiles du corps, avec une haute réso-
lution spatiale et temporelle. Les paramètres clés
des mouvements de la main et de la démarche peu-
vent être ainsi déterminés avec précision. L’article
résume et commente plusieurs études ayant utilisé
ces nouvelles méthodes. Les résultats montrent que
la schizophrénie est responsable d’un schéma spé-
cifique de déficit moteur avec une perturbation
prédominante des paramètres spatiaux. Le traite-
ment antipsychotique conventionnel aggrave habi-
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